Expanding access to mental health care

How we’re helping local clinics reach patients in need in their communities

Community Routes: Access to Mental Health Care—a partnership between Teva, Direct Relief and the National Association of Free and Charitable Clinics (NAFC)—is helping to advance health equity and quality care for underserved populations.

Teva is providing commonly used medicines that treat depression and anxiety as well as $2 million in grant funding over two years in California, Florida and New Jersey, to support innovative behavioral health services through local free and charitable clinics, tailored to meet the needs of their communities.

“The free and charitable clinics chosen for this initiative are already providing outstanding care in their communities, and this funding, generously provided by Teva, will allow them to do even more, by expanding life-saving mental health care to those who need it most.”
-Thomas Tighe, CEO and President, Direct Relief

“Through this program, clinics will be able to enhance and expand access to crucial mental health services for their communities. The NAFC is grateful that Direct Relief and Teva Pharmaceuticals not only recognize the barriers to care communities often face and the importance of mental health care, but that they also are taking steps to join with the NAFC and support our clinics on the ground to provide solutions and increased access to care.”
-Nicole Lamoureux, President and CEO, NAFC

Read about how we’re supporting clinics across Florida, New Jersey & California

Read more

Meet our 2022 grantees


Read about our partnership with Direct Relief and NAFC

Read more

Why mental health, and why now? In the U.S., one in five adults experience a mental health illness. That’s an alarming number, and rates have drastically increased over the past two years, particularly among already vulnerable populations, including racial and ethnic minorities and members of the LGBTQIA+ community. According to a nationwide survey we conducted with Morehouse School of Medicine, 84% of physicians reported an increase in new diagnoses of mental health conditions since the start of the COVID-19 pandemic.

Why this program? Advancing access to quality medicines is what we do, by making medicines more affordable and available to patients. Through this partnership, we are using both funds and our broad portfolio to help address the rising need for community-based mental health care.

Why these partners? This program takes a two-pronged approach to increasing access to mental health care, through donation of medicines for uninsured patients and grant funding to support innovative services to help address the broader eco-system of care through free and charitable clinics. The National Association of Free and Charitable Clinics (NAFC) is a network of more than 1,400 clinics providing accessible healthcare to more than 2 million underserved patients every year—and we are supporting NAFC clinics in California, Florida and New Jersey to help them deliver innovative mental health services. Direct Relief—Teva’s longstanding partner—is helping to deliver Teva medicines to free & charitable clinics within their network in these states. With the unique knowledge and expertise of these organizations, we can reach underserved populations with quality medicines and care, help advance health equity, and contribute to a long-lasting impact.

Why these states? California, Florida and New Jersey were selected for this pilot based on unmet mental health needs, encompassing urban, suburban, and rural populations.

Why these clinics? In this pilot, 11 clinics were selected as grant recipients based on their innovative and practical approaches to care for underserved and vulnerable patients experiencing mental and behavioral health issues, with a focus on depression and anxiety. Learnings from their initiatives will be shared more broadly with free and charitable clinics across the U.S.

Teva's Global Commitment to Access

As part of Teva’s environmental, social and governance (ESG) strategy, we leverage our portfolio, global footprint and experienced partners to get more of our medicines to more people in more places, including those who wouldn’t otherwise be able to access them. This program is one of eight access to medicines programs Teva committed to launch globally by 2025. We are also working with partners to reach vulnerable populations in Malawi, Botswana, Uganda, Ghana, Israel and France.

Share this article: